AbbVie Inc (USA)
Industry and Market Reports

 

List of associated reports

Below is a list of reports where AbbVie Inc (USA) is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than AbbVie Inc (USA) in the same report. This provides an indication of potential competitors or associated to AbbVie Inc (USA). The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Ocular Inflammation Global Clinical Trials Review, H2, 2016

Ocular Inflammation Global Clinical Trials Review, H2, 2016


2016-12-21
GlobalData's clinical trial report, “Ocular Inflammation Global Clinical Trials Review, H2, 2016" provides an overview of Ocular Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC4013CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC4013CTIDB
  • View Report: Research and Experts Market Report: Posterior Uveitis Global Clinical Trials Review, H2, 2016

    Posterior Uveitis Global Clinical Trials Review, H2, 2016


    2016-12-21
    GlobalData's clinical trial report, “Posterior Uveitis Global Clinical Trials Review, H2, 2016" provides an overview of Posterior Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Posterior...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC4009CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC4009CTIDB
  • View Report: Research and Experts Market Report: Intermediate Uveitis Global Clinical Trials Review, H2, 2016

    Intermediate Uveitis Global Clinical Trials Review, H2, 2016


    2016-12-21
    GlobalData's clinical trial report, “Intermediate Uveitis Global Clinical Trials Review, H2, 2016" provides an overview of Intermediate Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC4006CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC4006CTIDB
  • View Report: Research and Experts Market Report: Hidradenitis Suppurativa Global Clinical Trials Review, H2, 2016

    Hidradenitis Suppurativa Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, H2, 2016" provides an overview of Hidradenitis Suppurativa clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3998CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3998CTIDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma - Pipeline Review, H2 2016

    Recurrent Malignant Glioma - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Malignant Glioma – Pipeline Review, H2 2016, provides an overview of the Recurrent Malignant Glioma (Oncology) pipeline landscape.

    Recurrent malignant...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8908IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8908IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Progressive Supranuclear Palsy - Pipeline Review, H2 2016

    Progressive Supranuclear Palsy - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Supranuclear Palsy – Pipeline Review, H2 2016, provides an overview of the Progressive Supranuclear Palsy (Central Nervous System) pipeline landscape.

    Pr...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8855IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8855IDB
  • View Report: Research and Experts Market Report: Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2016

    Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Exocrine Pancreatic Insufficiency Global Clinical Trials Review, H2, 2016" provides an overview of Exocrine Pancreatic Insufficiency clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3924CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3924CTIDB
  • View Report: Research and Experts Market Report: Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine...

    Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Pipeline Review, H2 20


    2016-11-30
    Global Markets Direct’s, ‘Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0687TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0687TDB
  • View Report: Research and Experts Market Report: Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein...

    Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct’s, ‘Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0686TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0686TDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H2 2016

    Ovarian Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian cancer is any cancerous growth...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8866IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8866IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease – Pipeline Review, H2 2016, provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape.

    Parkinson'...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8863IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8863IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H2 2016

    Neuropathic Pain - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain – Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.

    Neuropathic pain, or...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8861IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8861IDB
  • View Report: Research and Experts Market Report: Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or...

    Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H2 2016’, provides in depth analysis on Induced Myeloid...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0677TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0677TDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H2 2016

    Breast Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Breast Cancer – Pipeline Review, H2 2016, provides an overview of the Breast Cancer (Oncology) pipeline landscape.

    Breast cancer is a cancer that develops from...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8871IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8871IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H2 2016

    Multiple Sclerosis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

    Multiple sclerosis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8845IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8845IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H2 2016

    Hypertension - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension – Pipeline Review, H2 2016, provides an overview of the Hypertension (Cardiovascular) pipeline landscape.

    Hypertension, also referred to as high...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8829IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8829IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Dystonia Global Clinical Trials Review, H2, 2016

    Dystonia Global Clinical Trials Review, H2, 2016


    2016-11-22
    GlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, H2, 2016" provides an overview of Dystonia clinical trials scenario. This report provides top line data relating to the clinical trials on Dystonia. Report includes...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3912CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3912CTIDB
  • View Report: Research and Experts Market Report: Enterocolitis Global Clinical Trials Review, H2, 2016

    Enterocolitis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Enterocolitis Global Clinical Trials Review, H2, 2016" provides an overview of Enterocolitis clinical trials scenario. This report provides top line data relating to the clinical trials on Enterocolitis....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3902CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3902CTIDB
  • View Report: Research and Experts Market Report: Atrial Flutter Global Clinical Trials Review, H2, 2016

    Atrial Flutter Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H2, 2016" provides an overview of Atrial Flutter clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3883CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3883CTIDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Medullary Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3877CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3877CTIDB
  • View Report: Research and Experts Market Report: Toxoplasmosis - Pipeline Review, H2 2016

    Toxoplasmosis - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis – Pipeline Review, H2 2016, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape.

    Toxoplasmosis is a disease that...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8813IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8813IDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H2 2016

    Neuroendocrine Tumors - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

    Neuroendocrine tumor begins...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8809IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8809IDB
  • View Report: Research and Experts Market Report: Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma...

    Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H2 2016’, provides in depth analysis on Bcl-2-Like...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0652TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0652TDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Nephrotic Syndrome - Pipeline Review, H2 2016

    Nephrotic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nephrotic Syndrome - Pipeline Review, H2 2016, provides an overview of the Nephrotic Syndrome (Genito Urinary System And Sex Hormones) pipeline landscape.

    Nephrotic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8753IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8753IDB
  • View Report: Research and Experts Market Report: Proteinuria Global Clinical Trials Review, H2, 2016

    Proteinuria Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Proteinuria Global Clinical Trials Review, H2, 2016" provides an overview of Proteinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Proteinuria. Report...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3872CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3872CTIDB
  • View Report: Research and Experts Market Report: Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016

    Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2016" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3861CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3861CTIDB
  • View Report: Research and Experts Market Report: Renal Failure Global Clinical Trials Review, H2, 2016

    Renal Failure Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2016" provides an overview of Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure....
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3859CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3859CTIDB
  • View Report: Research and Experts Market Report: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016

    End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3858CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3858CTIDB
  • View Report: Research and Experts Market Report: Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose]...

    Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC 2.4.2.30) - Pipeline Review, H2 2016’, provides in...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0635TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0635TDB
  • View Report: Research and Experts Market Report: Pontine Glioma - Pipeline Review, H2 2016

    Pontine Glioma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma – Pipeline Review, H2 2016, provides an overview of the Pontine Glioma (Oncology) pipeline landscape.

    Pontine gliomas are highly aggressive and...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8740IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8740IDB
  • View Report: Research and Experts Market Report: Behcet Disease - Pipeline Review, H2 2016

    Behcet Disease - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease – Pipeline Review, H2 2016, provides an overview of the Behcet Disease (Immunology) pipeline landscape.

    Behcet disease (BEH-chets), sometimes...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8734IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8734IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H2 2016

    Metastatic Colorectal Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Colorectal Cancer (Oncology) pipeline landscape.

    Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8728IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8728IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2016, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8721IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8721IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H2 2016

    Follicular Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Follicular Lymphoma – Pipeline Review, H2 2016, provides an overview of the Follicular Lymphoma (Oncology) pipeline landscape.

    Follicular lymphoma is a common...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8717IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8717IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8713IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8713IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2016

    Epithelial Ovarian Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian epithelial...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8712IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8712IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H2 2016

    Small-Cell Lung Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

    Small cell lung cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8706IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8706IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Market Report: Friedreich Ataxia Global Clinical Trials Review, H2, 2016

    Friedreich Ataxia Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H2, 2016" provides an overview of Friedreich Ataxia clinical trials scenario. This report provides top line data relating to the clinical trials on Friedreich...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3843CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3843CTIDB
  • View Report: Research and Experts Market Report: Cirrhosis Global Clinical Trials Review, H2, 2016

    Cirrhosis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Cirrhosis Global Clinical Trials Review, H2, 2016" provides an overview of Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cirrhosis. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3836CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3836CTIDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC...

    Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0612TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0612TDB
  • View Report: Research and Experts Market Report: Spinal Cord Injury - Pipeline Review, H2 2016

    Spinal Cord Injury - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury – Pipeline Review, H2 2016, provides an overview of the Spinal Cord Injury (Central Nervous System) pipeline landscape.

    Spinal cord injury...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8703IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8703IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H2 2016, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8688IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8687IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8687IDB
  • View Report: Research and Experts Market Report: Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2016

    Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Review, H2, 2016" provides an overview of Human Immunodeficiency Virus (HIV) Infections (AIDS) clinical trials scenario. This...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3831CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3831CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Global Clinical Trials Review, H2, 2016

    Osteoarthritis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H2, 2016" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis....
  • Market Report
  • Musculoskeletal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3830CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3830CTIDB
  • View Report: Research and Experts Market Report: Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2016

    Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Granulomatosis with Polyangiitis (Wegener Polyangiitis) Global Clinical Trials Review, H2, 2016" provides an overview of Granulomatosis with Polyangiitis (Wegener Polyangiitis) clinical trials scenario....
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3829CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3829CTIDB
  • View Report: Research and Experts Market Report: Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine...

    Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0589TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0589TDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or...

    Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016’, provides in depth analysis on Tumor Necrosis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0587TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0587TDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H2 2016

    Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape.

    Renal cell carcinoma (RCC,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8682IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H2 2016

    Psoriatic Arthritis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis – Pipeline Review, H2 2016, provides an overview of the Psoriatic Arthritis (Musculoskeletal Disorders) pipeline landscape.

    Psoriatic arthritis...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8680IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8680IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8673IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8673IDB
  • View Report: Research and Experts Market Report: Systemic Mastocytosis - Pipeline Review, H2 2016

    Systemic Mastocytosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Mastocytosis – Pipeline Review, H2 2016, provides an overview of the Systemic Mastocytosis (Gastrointestinal) pipeline landscape.

    Systemic mastocytosis...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8648IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8648IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis – Pipeline Review, H2 2016, provides an overview of the Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline landscape.

    Ankylosing...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8639IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8639IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016" provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) clinical trials scenario. This report provides top...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3814CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3814CTIDB
  • View Report: Research and Experts Market Report: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2016

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2016" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3812CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3812CTIDB
  • View Report: Research and Experts Market Report: Dyslipidemia Global Clinical Trials Review, H2, 2016

    Dyslipidemia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Dyslipidemia Global Clinical Trials Review, H2, 2016" provides an overview of Dyslipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyslipidemia....
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3809CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3809CTIDB
  • View Report: Research and Experts Market Report: Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2016

    Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2016" provides an overview of Left Ventricular Hypertrophy clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3807CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3807CTIDB
  • View Report: Research and Experts Market Report: Behcet Disease Global Clinical Trials Review, H2, 2016

    Behcet Disease Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Behcet Disease Global Clinical Trials Review, H2, 2016" provides an overview of Behcet Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Behcet Disease....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3805CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3805CTIDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016

    Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016" provides an overview of Secondary Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Hormonal Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3792CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3792CTIDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8644IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8644IDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma - Pipeline Review, H2 2016

    Burkitt Lymphoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burkitt Lymphoma – Pipeline Review, H2 2016, provides an overview of the Burkitt Lymphoma (Oncology) pipeline landscape.

    Burkitt lymphoma is a form of non-Hodgkin�...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8631IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8631IDB
  • View Report: Research and Experts Market Report: Hairy Cell Leukemia - Pipeline Review, H2 2016

    Hairy Cell Leukemia - Pipeline Review, H2 2016


    2016-10-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hairy Cell Leukemia – Pipeline Review, H2 2016, provides an overview of the Hairy Cell Leukemia (Oncology) pipeline landscape.

    Hairy cell leukemia is a rare,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8630IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8630IDB
  • View Report: Research and Experts Market Report: Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016

    Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Axial Spondyloarthritis Global Clinical Trials Review, H2, 2016" provides an overview of Axial Spondyloarthritis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Musculoskeletal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3789CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3789CTIDB
  • View Report: Research and Experts Market Report: Schizophrenia Global Clinical Trials Review, H2, 2016

    Schizophrenia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, H2, 2016" provides an overview of Schizophrenia clinical trials scenario. This report provides top line data relating to the clinical trials on Schizophrenia....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3779CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3779CTIDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Parkinson's Disease Global Clinical Trials Review, H2, 2016" provides an overview of Parkinson's Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3778CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3778CTIDB
  • View Report: Research and Experts Market Report: Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H2 2016

    Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct’s, ‘Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0561TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0561TDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2016, provides an overview of the Diffuse Large B-Cell Lymphoma (Oncology) pipeline landscape.

    Diffuse large...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8656IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8656IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2016

    Osteoarthritis Pain - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain – Pipeline Review, H2 2016, provides an overview of the Osteoarthritis Pain (Central Nervous System) pipeline landscape.

    Osteoarthritis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8600IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8600IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H2 2016

    Ulcerative Colitis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis – Pipeline Review, H2 2016, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.

    Ulcerative Colitis (Colitis...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8598IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8598IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2016

    Fallopian Tube Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer – Pipeline Review, H2 2016, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape.

    Fallopian tube cancer is...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8595IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8595IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H2 2016

    Asthma - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape.

    Asthma is a chronic disease involving the airways in...

  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8567IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8567IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape....
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8562IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8562IDB
  • View Report: Research and Experts Market Report: Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016

    Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections – Pipeline Review, H2 2016, provides an overview of the Influenza A Virus, H1N1 Subtype Infections (Infectious Disease)...
  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8560IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8560IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) – Pipeline Review, H2 2016, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) pipeline landscape.

    ...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8559IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8559IDB
  • View Report: Research and Experts Market Report: Kidney Fibrosis - Pipeline Review, H2 2016

    Kidney Fibrosis - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Fibrosis – Pipeline Review, H2 2016, provides an overview of the Kidney Fibrosis (Genito Urinary System And Sex Hormones) pipeline landscape.

    Accumulation...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8537IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8537IDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016

    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsing Remitting Multiple Sclerosis (RRMS) – Pipeline Review, H2 2016, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) (Central...
  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8533IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8533IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H2 2016

    Waldenstrom Macroglobulinemia - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Waldenstrom Macroglobulinemia – Pipeline Review, H2 2016, provides an overview of the Waldenstrom Macroglobulinemia (Oncology) pipeline landscape.

    Waldenstrom...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8527IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8527IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone Refractory Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Hormone Refractory Prostate Cancer (Oncology) pipeline landscape.

    Prostate...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8504IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8504IDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H2 2016

    Uveitis - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis – Pipeline Review, H2 2016, provides an overview of the Uveitis (Ophthalmology) pipeline landscape.

    Uveitis is swelling and irritation of the uvea,...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8544IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8544IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H2 2016

    Mild Cognitive Impairment - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment – Pipeline Review, H2 2016, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape.

    Mild...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8518IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8518IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H2 2016

    Hepatitis C - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C – Pipeline Review, H2 2016, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape.

    Hepatitis C is a contagious viral infection...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8516IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8516IDB
  • View Report: Research and Experts Project Profile: AbbVie Inc. - Strategy, SWOT and Corporate Finance Report

    AbbVie Inc. - Strategy, SWOT and Corporate Finance Report


    2017-01-31
    AbbVie Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing...
  • Project Profile
  • Life Sciences
  • United States
  • $175.00
  • Report 05IK-E38302B9-506B-4E28-9ECC-BE has a star rating of 4.1 out of 5
  • Go to More information on Report 05IK-E38302B9-506B-4E28-9ECC-BE
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2016" provides an overview of Crohn's Disease (Regional Enteritis) clinical trials scenario. This report provides top...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3756CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3756CTIDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis Global Clinical Trials Review, H2, 2016

    Ulcerative Colitis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2016" provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3742CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3742CTIDB
  • View Report: Research and Experts Market Report: Endometriosis Global Clinical Trials Review, H2, 2016

    Endometriosis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Endometriosis Global Clinical Trials Review, H2, 2016" provides an overview of Endometriosis clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3741CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3741CTIDB
  • View Report: Research and Experts Market Report: Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor...

    Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0548TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0548TDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H2 2016

    Psoriasis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8494IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8494IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H2 2016

    Lupus Nephritis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H2 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8490IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8490IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H2 2016

    Metastatic Melanoma - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8473IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8473IDB
  • View Report: Research and Experts Market Report: Ependymoma Global Clinical Trials Review, H2, 2016

    Ependymoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Ependymoma Global Clinical Trials Review, H2, 2016" provides an overview of Ependymoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ependymoma. Report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3736CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3736CTIDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

    Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Myeloma (Kahler Disease) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3734CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3734CTIDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016

    Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral T-Cell Lymphomas (PTCL) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3732CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3732CTIDB
  • View Report: Research and Experts Market Report: Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016

    Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Subependymal Giant Cell Astrocytoma clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3731CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3731CTIDB
  • View Report: Research and Experts Market Report: Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016

    Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016" provides an overview of Lymphoblastic Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3726CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3726CTIDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

    Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3725CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3725CTIDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3719CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3719CTIDB
  • View Report: Research and Experts Market Report: Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016

    Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2016" provides an overview of Juvenile Rheumatoid Arthritis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3702CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3702CTIDB
  • View Report: Research and Experts Market Report: Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016

    Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016’, provides in depth analysis on Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0521TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0521TDB
  • View Report: Research and Experts Market Report: Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016

    Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0511TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0511TDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H2 2016

    Chronic Pain - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H2 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8545IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8545IDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016

    Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8464IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8464IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H2 2016

    Endometriosis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H2 2016’, provides an overview of the Endometriosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometriosis,...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8457IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8457IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H2 2016

    Anxiety Disorders - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H2 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anxiety...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8433IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8433IDB
  • View Report: Research and Experts Market Report: Bone Marrow Transplant Rejection - Pipeline Review, H2 2016

    Bone Marrow Transplant Rejection - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Bone Marrow Transplant Rejection - Pipeline Review, H2 2016’, provides an overview of the Bone Marrow Transplant Rejection pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8428IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8428IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Current and Future Players

    Dyslipidemia - Current and Future Players


    2015-05-05
    GlobalData has released its pharma report, “Dyslipidemia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Dyslipidemia Market. The report identifies...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,995.00
  • Report 05IC-GDHC1056FPR has a star rating of 3.4 out of 5
  • Go to More information on Report 05IC-GDHC1056FPR
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016’, provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8420IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8420IDB
  • View Report: Research and Experts Market Report: Hepatitis C Global Clinical Trials Review, H2, 2016

    Hepatitis C Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Hepatitis C Global Clinical Trials Review, H2, 2016" provides an overview of Hepatitis C clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis C. Report...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3662CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3662CTIDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

    Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016" provides an overview of Glioblastoma Multiforme (GBM) clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3658CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3658CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H2 2016

    Osteoarthritis - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H2 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8387IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8387IDB
  • View Report: Research and Experts Market Report: Rectal Cancer - Pipeline Review, H2 2016

    Rectal Cancer - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H2 2016’, provides an overview of the Rectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rectal Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8371IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8371IDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer - Pipeline Review, H2 2016

    Medullary Thyroid Cancer - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H2 2016’, provides an overview of the Medullary Thyroid Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8369IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8369IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8354IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8354IDB
  • View Report: Research and Experts Market Report: Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016

    Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2016’, provides an overview of the Influenza A Virus, H3N2 Subtype Infections pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8352IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8352IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8349IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8349IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2016

    Mantle Cell Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mantle...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8348IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8348IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H2 2016

    Diabetic Nephropathy - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H2 2016’, provides an overview of the Diabetic Nephropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8347IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8347IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H2 2016

    Atopic Dermatitis - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H2 2016’, provides an overview of the Atopic Dermatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atopic...

  • Market Report
  • Dermatology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8341IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8341IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2016

    Indolent Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8340IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8340IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma - Current and Future Players

    Multiple Myeloma - Current and Future Players


    2015-11-01
    GlobalData has released its pharma report, “Multiple Myeloma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Multiple Myeloma Market. The report...
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1051FPR has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC1051FPR
  • View Report: Research and Experts Market Report: Supraventricular Tachycardia Global Clinical Trials Review, H2, 2016

    Supraventricular Tachycardia Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Supraventricular Tachycardia Global Clinical Trials Review, H2, 2016" provides an overview of Supraventricular Tachycardia clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3615CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3615CTIDB
  • View Report: Research and Experts Market Report: Intermittent Claudication Global Clinical Trials Review, H2, 2016

    Intermittent Claudication Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Intermittent Claudication Global Clinical Trials Review, H2, 2016" provides an overview of Intermittent Claudication clinical trials scenario. This report provides top line data relating to the clinical trials on Intermittent...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3597CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3597CTIDB
  • View Report: Research and Experts Market Report: Schizoaffective Disorder Global Clinical Trials Review, H2, 2016

    Schizoaffective Disorder Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Schizoaffective Disorder Global Clinical Trials Review, H2, 2016" provides an overview of Schizoaffective Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Schizoaffective...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3574CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3574CTIDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016

    Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsing Remitting Multiple Sclerosis (RRMS) clinical trials scenario. This report provides top line data...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3559CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3559CTIDB
  • View Report: Research and Experts Market Report: Ocular Pain Global Clinical Trials Review, H2, 2016

    Ocular Pain Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Ocular Pain Global Clinical Trials Review, H2, 2016" provides an overview of Ocular Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Pain. Report includes an...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3553CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3553CTIDB
  • View Report: Research and Experts Market Report: Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose]...

    Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or PARP2 or EC 2.4.2.30) - Pipeline Review, H2 2016


    2016-07-27
    ‘Poly [ADP Ribose] Polymerase 2 (ADP Ribosyltransferase Diphtheria Toxin Like 2 or NAD(+) ADP Ribosyltransferase 2 or Poly[ADP Ribose] Synthase 2 or PARP2 or EC 2.4.2.30) - Pipeline Review, H2 2016’, provides in depth analysis on Poly [ADP Ribose]...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0412TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0412TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0399TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0399TDB
  • View Report: Research and Experts Market Report: Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2016

    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2016


    2016-07-20
    ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2016’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8278IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8278IDB
  • View Report: Research and Experts Market Report: Alcohol Addiction - Pipeline Review, H2 2016

    Alcohol Addiction - Pipeline Review, H2 2016


    2016-07-20
    ‘Alcohol Addiction - Pipeline Review, H2 2016’, provides an overview of the Alcohol Addiction pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Alcohol Addiction, complete with analysis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8298IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8298IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016


    2016-07-20
    ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8297IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8297IDB
  • View Report: Research and Experts Market Report: Obsessive-Compulsive Disorder - Pipeline Review, H2 2016

    Obsessive-Compulsive Disorder - Pipeline Review, H2 2016


    2016-07-20
    ‘Obsessive-Compulsive Disorder - Pipeline Review, H2 2016’, provides an overview of the Obsessive-Compulsive Disorder pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obsessive-Compulsive...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8280IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8280IDB
  • View Report: Research and Experts Company Reports: Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review

    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review


    2016-08-17
    Biogen Inc (Biogen) is a global biotechnology company that discovers, develops, manufactures and commercializes therapies for treating neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company’s marketed product portfolio...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 01B4-GDPH1307FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 01B4-GDPH1307FSA
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016

    Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3527CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3527CTIDB
  • View Report: Research and Experts Market Report: Hypertriglyceridemia Global Clinical Trials Review, H1, 2016

    Hypertriglyceridemia Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Hypertriglyceridemia Global Clinical Trials Review, H1, 2016" provides an overview of Hypertriglyceridemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertriglyceridemia....
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3518CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3518CTIDB
  • View Report: Research and Experts Market Report: Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline...

    Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase C (Aurora 3 or...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0214TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0214TDB
  • View Report: Research and Experts Market Report: Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1)...

    Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase B (Aurora...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0213TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0213TDB
  • View Report: Research and Experts Market Report: Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review,...

    Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase A (Serine/Threonine-Protein...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0212TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0212TDB
  • View Report: Research and Experts Market Report: Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016

    Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) targeted pipeline therapeutics....
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0172TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0172TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review,...

    Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1 (Bcl-2-Like Protein 3 or Bcl-2-Related Protein EAT/Mcl1) - Pipeline Review, H1 2016’, provides in depth analysis on Induced Myeloid Leukemia Cell Differentiation...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0142TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0142TDB
  • View Report: Research and Experts Market Report: Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma...

    Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H1 2016’, provides in depth analysis on Bcl-2-Like...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0141TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0141TDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2016

    Neuropathic Pain - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuropathic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7966IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7966IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016

    Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Small-Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3500CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3500CTIDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

    B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Chronic Lymphocytic Leukemia clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3497CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3497CTIDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3485CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3485CTIDB
  • View Report: Research and Experts Market Report: Meningioma Global Clinical Trials Review, H1, 2016

    Meningioma Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Meningioma Global Clinical Trials Review, H1, 2016" provides an overview of Meningioma clinical trials scenario. This report provides top line data relating to the clinical trials on Meningioma. Report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3484CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3484CTIDB
  • View Report: Research and Experts Market Report: Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

    Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis


    2016-05-01
    GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion by 2024 in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). The main drivers of this growth will come from immune checkpoint...
  • Market Report
  • Oncology
  • Global
  • $10,995.00
  • Report 05IC-GDHC057POA has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC057POA
  • View Report: Research and Experts Market Report: Apoptosis

    Apoptosis


    2016-04-01
    Over the past few years, availability of apoptosis related products (drugs, kits and reagents) has increased enormously. Global market for apoptosis related products is expected to grow at a high CAGR of about 30% through 2010-2022, and the high growth...
  • Market Report
  • Healthcare
  • Global
  • $3,600.00
  • Report 05HF-MIR008 has a star rating of 4.8 out of 5
  • Go to More information on Report 05HF-MIR008
  • View Report: Research and Experts Market Report: Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT...

    Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Poly (ADP-Ribose) Polymerase 1 (ADP-Ribosyltransferase Diphtheria Toxin-Like 1 or PARP-1 or NAD(+) ADP-Ribosyltransferase 1 or ADPRT 1 or Poly[ADP-Ribose] Synthase 1 or EC 2.4.2.30) - Pipeline Review, H1 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0105TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0105TDB
  • View Report: Research and Experts Market Report: Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine...

    Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016’, provides in depth analysis on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0101TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0101TDB
  • View Report: Research and Experts Market Report: Progressive Supranuclear Palsy - Pipeline Review, H1 2016

    Progressive Supranuclear Palsy - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Progressive Supranuclear Palsy - Pipeline Review, H1 2016’, provides an overview of the Progressive Supranuclear Palsy pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8192IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8192IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7963IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7963IDB
  • View Report: Research and Experts Market Report: Psoriasis - Current and Future Players

    Psoriasis - Current and Future Players


    2016-04-13
    GlobalData has released its pharma report, “Psoriasis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Psoriasis Market. The report identifies...
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1044FPR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC1044FPR
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016

    Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3477CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3477CTIDB
  • View Report: Research and Experts Market Report: Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3474CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3474CTIDB
  • View Report: Research and Experts Market Report: Brenner Tumor Global Clinical Trials Review, H1, 2016

    Brenner Tumor Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2016" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner Tumor....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3471CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3471CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024


    2016-04-13
    Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC119PIDR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC119PIDR
  • View Report: Research and Experts Market Report: Indolent Lymphoma Global Clinical Trials Review, H1, 2016

    Indolent Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Indolent Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Indolent...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3447CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3447CTIDB
  • View Report: Research and Experts Market Report: Hairy Cell Leukemia Global Clinical Trials Review, H1, 2016

    Hairy Cell Leukemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hairy Cell Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of Hairy Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3445CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3445CTIDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3444CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3444CTIDB
  • View Report: Research and Experts Market Report: B-Cell Leukemia Global Clinical Trials Review, H1, 2016

    B-Cell Leukemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “B-Cell Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3442CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3442CTIDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy Global Clinical Trials Review, H1, 2016

    Diabetic Nephropathy Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3433CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3433CTIDB
  • View Report: Research and Experts Market Report: Wilms

    Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2016" provides an overview of Wilms' Tumor (Nephroblastoma) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3420CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3420CTIDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma Global Clinical Trials Review, H1, 2016

    Follicular Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Follicular Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3418CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3418CTIDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3417CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3417CTIDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer Global Clinical Trials Review, H1, 2016

    Pancreatic Cancer Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3415CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3415CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hodgkin...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3414CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3414CTIDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016

    Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2016" provides an overview of Glioblastoma Multiforme (GBM) clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3411CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3411CTIDB
  • View Report: Research and Experts Market Report: Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016

    Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016’, provides an overview of the Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8173IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8173IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2016

    Multiple Sclerosis - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Multiple Sclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Multiple...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7962IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7962IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2016

    Hypertension - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2016’, provides an overview of the Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypertension, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7972IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7972IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2016

    Interleukin 2 Receptor Subunit Alpha (TAC Antigen or p55 or CD25 or IL2RA) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Interleukin-2 Receptor Subunit Alpha (IL-2 Receptor Subunit Alpha or TAC Antigen or p55 or CD25) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin-2 Receptor Subunit Alpha (IL-2 Receptor Subunit...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0059TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0059TDB
  • View Report: Research and Experts Market Report: Axial Spondyloarthritis - Pipeline Review, H1 2016

    Axial Spondyloarthritis - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Axial Spondyloarthritis - Pipeline Review, H1 2016’, provides an overview of the Axial Spondyloarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8142IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8142IDB
  • View Report: Research and Experts Market Report: Behcet Disease - Pipeline Review, H1 2016

    Behcet Disease - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Behcet Disease - Pipeline Review, H1 2016’, provides an overview of the Behcet Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Behcet Disease,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8113IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8113IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2016

    Schizophrenia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Schizophrenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8107IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8107IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Testicular Cancer Global Clinical Trials Review, H1, 2016

    Testicular Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Testicular...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3408CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3408CTIDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016

    Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Fallopian Tube Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3407CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3407CTIDB
  • View Report: Research and Experts Market Report: Ovarian Cancer Global Clinical Trials Review, H1, 2016

    Ovarian Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3404CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3404CTIDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer Global Clinical Trials Review, H1, 2016

    Peritoneal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Peritoneal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Peritoneal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Peritoneal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3400CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3400CTIDB
  • View Report: Research and Experts Market Report: Hyperthyroidism Global Clinical Trials Review, H1, 2016

    Hyperthyroidism Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Hyperthyroidism Global Clinical Trials Review, H1, 2016" provides an overview of Hyperthyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperthyroidism...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3398CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3398CTIDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma Global Clinical Trials Review, H1, 2016

    Burkitt Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3397CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3397CTIDB
  • View Report: Research and Experts Market Report: Thymus Cancer Global Clinical Trials Review, H1, 2016

    Thymus Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Thymus Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Thymus Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Thymus Cancer....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3393CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3393CTIDB
  • View Report: Research and Experts Market Report: Anal Cancer Global Clinical Trials Review, H1, 2016

    Anal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Anal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Anal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Cancer. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3392CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3392CTIDB
  • View Report: Research and Experts Market Report: Hyperparathyroidism Global Clinical Trials Review, H1, 2016

    Hyperparathyroidism Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, H1, 2016" provides an overview of Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3391CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3391CTIDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8003IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8003IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2016

    Epithelial Ovarian Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Epithelial Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8000IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8000IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2016

    Follicular Lymphoma - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Follicular Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Follicular...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7999IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7999IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2016

    Small-Cell Lung Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Small-Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7991IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7991IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2016

    Metastatic Colorectal Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7985IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7985IDB
  • View Report: Research and Experts Market Report: Systemic Mastocytosis - Pipeline Review, H1 2016

    Systemic Mastocytosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Systemic Mastocytosis - Pipeline Review, H1 2016’, provides an overview of the Systemic Mastocytosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8058IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8058IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016’, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8024IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8024IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8019IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8019IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8017IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8017IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2016

    Psoriatic Arthritis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2016’, provides an overview of the Psoriatic Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8010IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8010IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7986IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7986IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2016

    Renal Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Renal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7981IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7981IDB
  • View Report: Research and Experts Market Report: Hairy Cell Leukemia - Pipeline Review, H1 2016

    Hairy Cell Leukemia - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H1 2016’, provides an overview of the Hairy Cell Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hairy...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8051IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8051IDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma - Pipeline Review, H1 2016

    Burkitt Lymphoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Burkitt Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Burkitt Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Burkitt Lymphoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8048IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8048IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7988IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7988IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7978IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7978IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016

    Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016" provides an overview of Waldenstrom Macroglobulinemia clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3387CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3387CTIDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis Global Clinical Trials Review, H1, 2016

    Psoriatic Arthritis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H1, 2016" provides an overview of Psoriatic Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3384CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3384CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2016

    Osteoarthritis Pain - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7825IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7825IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7820IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7820IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H1 2016

    Fallopian Tube Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2016’, provides an overview of the Fallopian Tube Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7816IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2016

    Ulcerative Colitis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2016’, provides an overview of the Ulcerative Colitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ulcerative...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7601IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7601IDB
  • View Report: Research and Experts Market Report: Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016

    Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3351CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3351CTIDB
  • View Report: Research and Experts Market Report: Congenital Heart Disease Global Clinical Trials Review, H1, 2016

    Congenital Heart Disease Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Congenital Heart Disease Global Clinical Trials Review, H1, 2016" provides an overview of Congenital Heart Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3345CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3345CTIDB
  • View Report: Research and Experts Market Report: Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016

    Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Cardiovascular Inflammation Global Clinical Trials Review, H1, 2016" provides an overview of Cardiovascular Inflammation clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3342CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3342CTIDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2016" provides an overview of Ankylosing Spondylitis (Bekhterev's Disease) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3334CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3334CTIDB
  • View Report: Research and Experts Market Report: Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2016

    Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Ductal Adenocarcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7844IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7844IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H1 2016

    Mild Cognitive Impairment - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Mild Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7841IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7841IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016

    Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016’, provides an overview of the Waldenstrom Macroglobulinemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7840IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7840IDB
  • View Report: Research and Experts Market Report: Kidney Fibrosis - Pipeline Review, H1 2016

    Kidney Fibrosis - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Kidney Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Kidney Fibrosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7834IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7834IDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016

    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016’, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7831IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7831IDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H1 2016

    Uveitis - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Uveitis - Pipeline Review, H1 2016’, provides an overview of the Uveitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Uveitis, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7827IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7827IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7822IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7822IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H1 2016

    Hepatitis C - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2016’, provides an overview of the Hepatitis C pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7638IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7638IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H1 2016

    Lupus Nephritis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7856IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7856IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2016

    Metastatic Melanoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7691IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7691IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2016

    Chronic Pain - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7690IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7690IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7689IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7689IDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016

    Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2016’, provides an overview of the Graft Versus Host Disease (GVHD) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7700IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7700IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7699IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7699IDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer - Pipeline Review, H1 2016

    Peritoneal Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2016’, provides an overview of the Peritoneal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Peritoneal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7697IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7697IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2016

    Cognitive Impairment - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cognitive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7696IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7696IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H1 2016

    Endometriosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2016’, provides an overview of the Endometriosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometriosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7713IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7713IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H1 2016

    Anxiety Disorders - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anxiety...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7698IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7698IDB
  • View Report: Research and Experts Market Report: Sarcoidosis Global Clinical Trials Review, H1, 2016

    Sarcoidosis Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Sarcoidosis Global Clinical Trials Review, H1, 2016" provides an overview of Sarcoidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Sarcoidosis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3323CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3323CTIDB
  • View Report: Research and Experts Market Report: Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016

    Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2016" provides an overview of Hidradenitis Suppurativa clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3306CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3306CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2016

    Osteoarthritis - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7811IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7811IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016’, provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7714IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7714IDB
  • View Report: Research and Experts Market Report: Traumatic Brain Injury Global Clinical Trials Review, H1, 2016

    Traumatic Brain Injury Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Traumatic Brain Injury Global Clinical Trials Review, H1, 2016" provides an overview of Traumatic Brain Injury clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3295CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3295CTIDB
  • View Report: Research and Experts Market Report: Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2016

    Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Bronchopulmonary Dysplasia Global Clinical Trials Review, H1, 2016" provides an overview of Bronchopulmonary Dysplasia clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3282CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3282CTIDB
  • View Report: Research and Experts Market Report: Rectal Cancer - Pipeline Review, H1 2016

    Rectal Cancer - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Rectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rectal Cancer,...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7771IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7771IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Small Cell Lung Cancer (SCLC) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Initially considered a curable disease due to substantial sensitivity to first-line chemotherapies, small cell lung cancer (SCLC) remains a fatal disease with poor outcomes due to high relapse rates, with the majority of patients surviving one year or...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC055POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC055POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Glioblastoma - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Glioblastoma - Opportunity Analysis and Forecasts to 2024


    2015-12-22
    Glioblastoma multiforme (GBM) is characterized as a disease with some of the highest unmet needs in oncology, with patients having a median overall survival (OS) of between one and two years. The lack of therapies is primarily due to the inability of...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC053POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC053POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024


    2016-01-01
    Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, arteries, veins or capillaries. The different forms of vasculitis are classified by the size and location of the affected blood vessels . This report specifical...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC045POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC045POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: B-Cell Non-Hodgkin

    OpportunityAnalyzer: B-Cell Non-Hodgkin's Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen....
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC018POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC018POA
  • View Report: Research and Experts Company Reports: Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile

    Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Amgen Inc. (Amgen) is a biotechnology company. It undertakes the discovery, development, manufacture and commercialization of innovative human therapeutics. The company pioneered the development of new products based on advances in recombinant DNA and...
  • Company Reports
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME3778D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME3778D
  • View Report: Research and Experts Company Reports: Biogen, Inc. (BIIB) - Medical Equipment - Deals and Alliances Profile

    Biogen, Inc. (BIIB) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Biogen, Inc. (Biogen) is a global biotechnology company that discovers, develops, manufactures and commercializes therapies for treating neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company’s marketed product portfolio...
  • Company Reports
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME1307D has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDME1307D
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2016

    Indolent Lymphoma - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7663IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7663IDB
  • View Report: Research and Experts Market Report: Alcohol Addiction - Pipeline Review, H1 2016

    Alcohol Addiction - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Alcohol Addiction - Pipeline Review, H1 2016’, provides an overview of the Alcohol Addiction pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Alcohol...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7578IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7578IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) pipeline landscape.

    The report provides...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7562IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7562IDB
  • View Report: Research and Experts Market Report: Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2016

    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2016’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7659IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7659IDB
  • View Report: Research and Experts Market Report: Obsessive-Compulsive Disorder - Pipeline Review, H1 2016

    Obsessive-Compulsive Disorder - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Pipeline Review, H1 2016’, provides an overview of the Obsessive-Compulsive Disorder pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7579IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7579IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Global Clinical Trials Review, H1, 2016

    Osteoarthritis Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis....
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3231CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3231CTIDB
  • View Report: Research and Experts Market Report: Friedreich Ataxia Global Clinical Trials Review, H1, 2016

    Friedreich Ataxia Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H1, 2016" provides an overview of Friedreich Ataxia clinical trials scenario. This report provides top line data relating to the clinical trials on Friedreich...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3222CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3222CTIDB
  • View Report: Research and Experts Market Report: Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016

    Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Neuroendocrine Carcinoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3215CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3215CTIDB
  • View Report: Research and Experts Market Report: Uveitis Global Clinical Trials Review, H1, 2016

    Uveitis Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H1, 2016" provides an overview of Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3212CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3212CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Multiple Myeloma - Global Drug Forecast and Market Analysis to 2023

    PharmaPoint: Multiple Myeloma - Global Drug Forecast and Market Analysis to 2023


    2015-11-01
    The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is set to undergo substantial growth between 2013 and 2023. The main drivers of growth will be the launch of monoclonal antibodies (mAbs) Empliciti and daratum...
  • Market Report
  • Healthcare
  • Global
  • $10,995.00
  • Report 05IC-GDHC114PIDR has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC114PIDR
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H2 2015

    Lupus Nephritis - Pipeline Review, H2 2015


    2015-10-30
    Lupus Nephritis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H2 2015’, provides an overview of the Lupus Nephritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7244IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7244IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2015

    Osteoarthritis Pain - Pipeline Review, H2 2015


    2015-10-30
    Osteoarthritis Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H2 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7221IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7221IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Epithelial Ovarian Cancer - Pipeline Review, H2 2015


    2015-10-30
    Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7214IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7214IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-10-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7212IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7212IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015


    2015-10-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7211IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7211IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Mantle Cell Lymphoma - Pipeline Review, H2 2015


    2015-10-21
    Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6961IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6961IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H2 2015

    Endometriosis - Pipeline Review, H2 2015


    2015-10-21
    Endometriosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H2 2015’, provides an overview of the Endometriosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6846IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6846IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H2 2015

    Brain Cancer - Pipeline Review, H2 2015


    2015-10-21
    Brain Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6838IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6838IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015


    2015-10-14
    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2015’, provides an overview of the...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6856IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6856IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Refractory Multiple Myeloma - Pipeline Review, H2 2015


    2015-09-30
    Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7074IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7074IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H2 2015

    Cognitive Impairment - Pipeline Review, H2 2015


    2015-09-30
    Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7070IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7070IDB
  • View Report: Research and Experts Market Report: Memory Impairment - Pipeline Review, H2 2015

    Memory Impairment - Pipeline Review, H2 2015


    2015-09-30
    Memory Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Memory Impairment - Pipeline Review, H2 2015’, provides an overview of the Memory Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6978IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6978IDB
  • View Report: Research and Experts Market Report: Alcohol Addiction - Pipeline Review, H2 2015

    Alcohol Addiction - Pipeline Review, H2 2015


    2015-09-30
    Alcohol Addiction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Alcohol Addiction - Pipeline Review, H2 2015’, provides an overview of the Alcohol Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6970IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6970IDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H2 2015

    Uveitis - Pipeline Review, H2 2015


    2015-09-23
    Uveitis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Uveitis - Pipeline Review, H2 2015’, provides an overview of the Uveitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7087IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7087IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-09-23
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7077IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7077IDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

    Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015


    2015-09-23
    Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7076IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7076IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2015

    Fallopian Tube Cancer - Pipeline Review, H2 2015


    2015-09-23
    Fallopian Tube Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H2 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7075IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7075IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Systemic Lupus Erythematosus - Pipeline Review, H2 2015


    2015-08-31
    Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7059IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7059IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015


    2015-08-31
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6990IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6990IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2015

    Indolent Lymphoma - Pipeline Review, H2 2015


    2015-08-31
    Indolent Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6983IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6983IDB
  • View Report: Research and Experts Market Report: Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015


    2015-08-31
    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6982IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6982IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2015

    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2015


    2015-08-26
    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2015’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6999IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6999IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Hidradenitis Suppurativa - Pipeline Review, H2 2015

    Hidradenitis Suppurativa - Pipeline Review, H2 2015


    2015-08-12
    Hidradenitis Suppurativa - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Hidradenitis Suppurativa - Pipeline Review, H2 2015’, provides an overview of the Hidradenitis Suppurativa’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7040IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC7040IDB
  • View Report: Research and Experts Market Report: Obsessive-Compulsive Disorder - Pipeline Review, H2 2015

    Obsessive-Compulsive Disorder - Pipeline Review, H2 2015


    2015-07-31
    Obsessive-Compulsive Disorder - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Pipeline Review, H2 2015’, provides an overview of the Obsessive-Compulsive Disorder’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6878IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6878IDB
  • View Report: Research and Experts Market Report: Brain Metastasis - Pipeline Review, H2 2015

    Brain Metastasis - Pipeline Review, H2 2015


    2015-07-29
    Brain Metastasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Brain metastasis - Pipeline Review, H2 2015’, provides an overview of the Brain metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6938IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6938IDB
  • View Report: Research and Experts Market Report: Rectal Cancer - Pipeline Review, H2 2015

    Rectal Cancer - Pipeline Review, H2 2015


    2015-07-29
    Rectal Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H2 2015’, provides an overview of the Rectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6892IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6892IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2015

    Metastatic Breast Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6507IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6507IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2015

    Liver Cancer - Pipeline Review, H1 2015


    2015-06-30
    Liver Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6563IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6563IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Metastatic Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6570IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6570IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic Lymphocytic Leukemia (CLL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6567IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6567IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H1 2015


    2015-06-30
    Parkinson's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6562IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6562IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6509IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6509IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Hepatocellular Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6499IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6499IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2015

    Multiple Sclerosis - Pipeline Review, H1 2015


    2015-06-30
    Multiple Sclerosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6497IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6497IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2015

    Osteoarthritis - Pipeline Review, H1 2015


    2015-06-30
    Osteoarthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6571IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6571IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2015

    Hypertension - Pipeline Review, H1 2015


    2015-06-30
    Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6565IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6565IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer Squamous...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6515IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6515IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-06-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6519IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6519IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6518IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6518IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6516IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6516IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-24
    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Refractory Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6697IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6697IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2015

    Follicular Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Follicular Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6690IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6690IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Systemic Lupus Erythematosus - Pipeline Review, H1 2015


    2015-06-24
    Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6687IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6687IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Small-Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-24
    Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6686IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6686IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6684IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6684IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-17
    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Relapsed Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6699IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6699IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Epithelial Ovarian Cancer - Pipeline Review, H1 2015


    2015-05-29
    Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6521IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6521IDB
  • View Report: Research and Experts Market Report: Brain Metastasis - Pipeline Review, H1 2015

    Brain Metastasis - Pipeline Review, H1 2015


    2015-05-29
    Brain Metastasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Brain Metastasis - Pipeline Review, H1 2015’, provides an overview of the Brain Metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6593IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6593IDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015


    2015-05-29
    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015’, provides an overview of the Relapsing Remitting Multiple...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6590IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6590IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2015

    Psoriatic Arthritis - Pipeline Review, H1 2015


    2015-05-29
    Psoriatic Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2015’, provides an overview of the Psoriatic Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6589IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6589IDB
  • View Report: Research and Experts Market Report: Benign Prostatic Hyperplasia - Pipeline Review, H1 2015

    Benign Prostatic Hyperplasia - Pipeline Review, H1 2015


    2015-05-29
    Benign Prostatic Hyperplasia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Benign Prostatic Hyperplasia - Pipeline Review, H1 2015’, provides an overview of the Benign Prostatic Hyperplasia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6531IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6531IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2015

    Osteoarthritis Pain - Pipeline Review, H1 2015


    2015-05-29
    Osteoarthritis Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6526IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6526IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015

    Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015


    2015-04-30
    Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015’, provides an overview of the Waldenstrom Macroglobulinemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6603IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6603IDB
  • View Report: Research and Experts Market Report: Kidney Fibrosis - Pipeline Review, H1 2015

    Kidney Fibrosis - Pipeline Review, H1 2015


    2015-04-30
    Kidney Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Kidney Fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6602IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6602IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H1 2015

    Lupus Nephritis - Pipeline Review, H1 2015


    2015-04-30
    Lupus Nephritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2015’, provides an overview of the Lupus Nephritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6550IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6550IDB
  • View Report: Research and Experts Market Report: Tauopathies - Pipeline Review, H1 2015

    Tauopathies - Pipeline Review, H1 2015


    2015-04-29
    Tauopathies - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tauopathies - Pipeline Review, H1 2015’, provides an overview of the Tauopathies’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6620IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6620IDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Relapsed Multiple Myeloma - Pipeline Review, H1 2015


    2015-03-31
    Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Relapsed Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6247IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6247IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2015

    Cognitive Impairment - Pipeline Review, H1 2015


    2015-03-31
    Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6243IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6243IDB
  • View Report: Research and Experts Market Report: Addiction - Pipeline Review, H1 2015

    Addiction - Pipeline Review, H1 2015


    2015-03-31
    Addiction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Addiction - Pipeline Review, H1 2015’, provides an overview of the Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6241IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6241IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Nicotine Addiction - Pipeline Review, H1 2015

    Nicotine Addiction - Pipeline Review, H1 2015


    2015-03-19
    Nicotine Addiction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Nicotine Addiction - Pipeline Review, H1 2015’, provides an overview of the Nicotine Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6422IDB has a star rating of 3.2 out of 5
  • Go to More information on Report 05IB-GMDHC6422IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-03-19
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6250IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6250IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H1 2015

    Fallopian Tube Cancer - Pipeline Review, H1 2015


    2015-03-19
    Fallopian Tube Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6248IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6248IDB
  • View Report: Research and Experts Market Report: Uveitis - Pipeline Review, H1 2015

    Uveitis - Pipeline Review, H1 2015


    2015-03-11
    Uveitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Uveitis - Pipeline Review, H1 2015’, provides an overview of the Uveitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6260IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6260IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Hidradenitis Suppurativa - Pipeline Review, H1 2015

    Hidradenitis Suppurativa - Pipeline Review, H1 2015


    2015-01-30
    Hidradenitis Suppurativa - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hidradenitis Suppurativa - Pipeline Review, H1 2015’, provides an overview of the Hidradenitis Suppurativa’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6218IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6218IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H1 2015

    Anxiety Disorders - Pipeline Review, H1 2015


    2015-02-10
    Anxiety Disorders - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2015’, provides an overview of the Anxiety Disorders’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6131IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6131IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2015

    Chronic Pain - Pipeline Review, H1 2015


    2015-02-10
    Chronic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2015’, provides an overview of the Chronic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6129IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6129IDB
  • View Report: Research and Experts Market Report: Hyperalgesia - Pipeline Review, H1 2015

    Hyperalgesia - Pipeline Review, H1 2015


    2015-01-30
    Hyperalgesia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hyperalgesia - Pipeline Review, H1 2015’, provides an overview of the Hyperalgesia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6198IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6198IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Mantle Cell Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6139IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6139IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H1 2015

    Diabetic Nephropathy - Pipeline Review, H1 2015


    2015-01-30
    Diabetic Nephropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6138IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6138IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H1 2015

    Refractory Multiple Myeloma - Pipeline Review, H1 2015


    2015-01-30
    Refractory Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6135IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6135IDB
  • View Report: Research and Experts Market Report: Women Infertility - Pipeline Review, H1 2015

    Women Infertility - Pipeline Review, H1 2015


    2015-01-30
    Women Infertility - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Women Infertility - Pipeline Review, H1 2015’, provides an overview of the Women Infertility’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6133IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6133IDB
  • View Report: Research and Experts Market Report: Rectal Cancer - Pipeline Review, H1 2015

    Rectal Cancer - Pipeline Review, H1 2015


    2015-01-30
    Rectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Rectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6078IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6078IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H1 2015

    Hepatitis C - Pipeline Review, H1 2015


    2015-01-30
    Hepatitis C - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2015’, provides an overview of the Hepatitis C’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6008IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6008IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2015


    2015-01-30
    Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6229IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6229IDB
  • View Report: Research and Experts Market Report: Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015

    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015


    2015-01-30
    Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H1 2015’, provides an overview of the Uterine Leiomyoma (Uterine Fibroids)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6177IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6177IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015


    2015-01-30
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6168IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6168IDB
  • View Report: Research and Experts Market Report: Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-01-30
    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6161IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6161IDB
  • View Report: Research and Experts Market Report: Alcohol Addiction - Pipeline Review, H1 2015

    Alcohol Addiction - Pipeline Review, H1 2015


    2015-01-30
    Alcohol Addiction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alcohol Addiction - Pipeline Review, H1 2015’, provides an overview of the Alcohol Addiction’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6149IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6149IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2015

    Metastatic Melanoma - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6013IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6013IDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer - Pipeline Review, H1 2015

    Peritoneal Cancer - Pipeline Review, H1 2015


    2015-01-22
    Peritoneal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6120IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6120IDB
  • View Report: Research and Experts Market Report: Obsessive-Compulsive Disorder - Pipeline Review, H1 2015

    Obsessive-Compulsive Disorder - Pipeline Review, H1 2015


    2015-01-22
    Obsessive-Compulsive Disorder - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Pipeline Review, H1 2015’, provides an overview of the Obsessive-Compulsive Disorder’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6064IDB has a star rating of 3.0 out of 5
  • Go to More information on Report 05IB-GMDHC6064IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015

    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015


    2015-01-22
    Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2015’, provides an overview of the...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6042IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6042IDB
  • View Report: Research and Experts Market Report: Endometriosis - Pipeline Review, H1 2015

    Endometriosis - Pipeline Review, H1 2015


    2015-01-22
    Endometriosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Endometriosis - Pipeline Review, H1 2015’, provides an overview of the Endometriosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6032IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6032IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H1 2015

    Brain Cancer - Pipeline Review, H1 2015


    2015-01-22
    Brain Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H1 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6024IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6024IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015


    2015-01-22
    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6022IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6022IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Company Reports: AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review

    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review


    2017-04-26
    AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunolo...
  • Company Reports
  • Non Specified Industry Company Reports
  • United States
  • $125.00
  • Report 05IC-GDPH430057FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH430057FSA
  • View Report: Research and Experts Company Reports: Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review

    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review


    2017-03-01
    Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab),...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH1307FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH1307FSA
  • View Report: Research and Experts Company Reports: Tesaro Inc (TSRO) - Financial and Strategic SWOT Analysis Review

    Tesaro Inc (TSRO) - Financial and Strategic SWOT Analysis Review


    2017-04-11
    Tesaro Inc (Tesaro) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates, comprising rolapitant, niraparib, and the product candidates under its immuno-oncology platform. VARUBI,...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH281619FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH281619FSA
  • View Report: Research and Experts Company Reports: Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review

    Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review


    2017-04-05
    Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes products in cardiovascular therapeutic area. The company's lead product Vascepa (icosapent ethyl) is a single-molecule prescription product which comprises...
  • Company Reports
  • Life Sciences
  • Ireland
  • $125.00
  • Report 05IC-GDPH58486FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH58486FSA
  • View Report: Research and Experts Company Reports: Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review

    Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review


    2017-04-26
    Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems to improve the quality of life for patients. The company has one marketed product, namely, Subsys, a sublingual...
  • Company Reports
  • Non Specified Industry Company Reports
  • United States
  • $125.00
  • Report 05IC-GDPH123460FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH123460FSA
  • View Report: Research and Experts Company Reports: Antares Pharma, Inc. (ATRS) - Financial and Strategic SWOT Analysis Review

    Antares Pharma, Inc. (ATRS) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    Antares Pharma, Inc. (Antares Pharma) is a specialty pharmaceutical company that focuses on development and commercialization of self-injection pharmaceutical drugs and technologies and topical gel-based products. The company has product OTREXUP which...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH3783FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH3783FSA
  • View Report: Research and Experts Company Reports: Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review

    Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review


    2017-04-05
    Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes new pharmaceutical products for the treatment of neurological and endocrine related diseases and disorders. The company’s products help to treat disease conditions such...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH18235FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH18235FSA
  • View Report: Research and Experts Market Report: Psoriasis Global Clinical Trials Review, H2, 2015

    Psoriasis Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H2, 2015" provides an overview of Psoriasis clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriasis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3000CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3000CTIDB
  • View Report: Research and Experts Market Report: Hypercalcemia Global Clinical Trials Review, H2, 2015

    Hypercalcemia Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Hypercalcemia Global Clinical Trials Review, H2, 2015" provides an overview of Hypercalcemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypercalcemia....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2998CTIDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC2998CTIDB
  • View Report: Research and Experts Market Report: Leiomyoma Global Clinical Trials Review, H2, 2015

    Leiomyoma Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Leiomyoma Global Clinical Trials Review, H2, 2015" provides an overview of Leiomyoma clinical trials scenario. This report provides top line data relating to the clinical trials on Leiomyoma. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2991CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC2991CTIDB
  • View Report: Research and Experts Market Report: Polyarticular Idiopathic Juvenile Arthritis Global Clinical Trials Review, H2, 2015

    Polyarticular Idiopathic Juvenile Arthritis Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Polyarticular Idiopathic Juvenile Arthritis Global Clinical Trials Review, H2, 2015" provides an overview of Polyarticular Idiopathic Juvenile Arthritis clinical trials scenario. This report provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2959CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC2959CTIDB
  • View Report: Research and Experts Market Report: Amenorrhea Global Clinical Trials Review, H2, 2015

    Amenorrhea Global Clinical Trials Review, H2, 2015


    2015-12-09
    GlobalData's clinical trial report, “Amenorrhea Global Clinical Trials Review, H2, 2015" provides an overview of Amenorrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Amenorrhea. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3051CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3051CTIDB
  • View Report: Research and Experts Market Report: Menorrhagia Global Clinical Trials Review, H2, 2015

    Menorrhagia Global Clinical Trials Review, H2, 2015


    2015-12-04
    GlobalData's clinical trial report, “Menorrhagia Global Clinical Trials Review, H2, 2015" provides an overview of Menorrhagia clinical trials scenario. This report provides top line data relating to the clinical trials on Menorrhagia. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3043CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3043CTIDB
  • View Report: Research and Experts Market Report: Metrorrhagia (Abnormal Uterine Bleeding) Global Clinical Trials Review, H2, 2015

    Metrorrhagia (Abnormal Uterine Bleeding) Global Clinical Trials Review, H2, 2015


    2015-12-04
    GlobalData's clinical trial report, “Metrorrhagia (Abnormal Uterine Bleeding) Global Clinical Trials Review, H2, 2015" provides an overview of Metrorrhagia (Abnormal Uterine Bleeding) clinical trials scenario. This report provides top line...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3042CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3042CTIDB
  • View Report: Research and Experts Market Report: Menstrual Disorders Global Clinical Trials Review, H2, 2015

    Menstrual Disorders Global Clinical Trials Review, H2, 2015


    2015-12-04
    GlobalData's clinical trial report, “Menstrual Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Menstrual Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3037CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3037CTIDB
  • View Report: Research and Experts Industry Report: Apoptosis

    Apoptosis


    2015-10-01
    Apoptosis Market research report gives an insight into Apoptosis Mechanism, by Molecular Pathways, Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators, p53 Modulators and Other. The study also focuses on major diseases...
  • Industry Report
  • Biotechnology
  • Global
  • $5,400.00
  • Report 05HF-RITMIR008 has a star rating of 4.4 out of 5
  • Go to More information on Report 05HF-RITMIR008
  • View Report: Research and Experts Industry Report: Unnatural Amino Acids

    Unnatural Amino Acids


    2015-09-01
    Unnatural Amino acids Market research report gives an insight into the different types of Unnatural Amino Acids (ß-Amino Acids, ß-Amino Acid Derivatives, Cyclic Amino Acids & Derivatives, D-Amino Acids, D-Amino Acid Derivatives, DL-Amino...
  • Industry Report
  • Biotechnology
  • Global
  • $8,100.00
  • Report 05HF-RITMIR027 has a star rating of 4.4 out of 5
  • Go to More information on Report 05HF-RITMIR027
  • Industries and Sectors

    • Healthcare (14)
    • Dermatology (2)
    • Oncology (69)
    • Central Nervous... (21)
    • Gastrointestinal... (8)
    • Pharmaceuticals (131)
    • Immunology (10)
    • Cardiovascular (7)
    • Infectious Disease... (6)
    • Genitourinary Disorders... (4)
    • Musculoskeletal (2)
    • Musculoskeletal... (2)
    • Metabolic Disorders... (4)
    • Hormonal Disorders... (1)
    • Respiratory (1)
    • Life Sciences (108)
    • Construction Materials... (16)
    • Medical Devices (2)
    • Non Specified Industry... (2)
    • Biotechnology (2)

    Geographic Regions

    • Global (401)
    • United States (10)
    • Ireland (1)

    Report Types

    • Market Report (399)
    • Project Profile (1)
    • Company Reports (10)
    • Industry Report (2)

    Return to Company List

    Page created and rendered - Cache updated [5.11373s]

    --